TABLE 2.
Use of antithrombotic agents among study population.
| Overall (n = 6,140) | |
|---|---|
| Antithrombotic agents (n, %) | 3,805 (62.0) |
| Anticoagulant agents (n, %) | 3,517 (57.3) |
| Anticoagulant agents only | 3,114 (50.7) |
| Heparin (n, %) | 3,497 (57.0) |
| UFH only | 2,101 (34.2) |
| LMWH only | 920 (15.0) |
| LMWH and UFH | 476 (7.8) |
| Antiplatelet agents (n, %) | 691 (11.3) |
| Antiplatelet agents only | 288 (4.7) |
UFH: unfractionated heparin; LWMH: low molecular weight heparin.